scispace - formally typeset
G

Guido Silvestri

Researcher at Yerkes National Primate Research Center

Publications -  340
Citations -  26221

Guido Silvestri is an academic researcher from Yerkes National Primate Research Center. The author has contributed to research in topics: Simian immunodeficiency virus & Immune system. The author has an hindex of 77, co-authored 322 publications receiving 23499 citations. Previous affiliations of Guido Silvestri include Scripps Health & Scripps Research Institute.

Papers
More filters
Journal ArticleDOI

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

TL;DR: It is shown that increased lipopolysaccharide is bioactive in vivo and correlates with measures of innate and adaptive immune activation, which establish a mechanism for chronic immune activation in the context of a compromised gastrointestinal mucosal surface and provide new directions for therapeutic interventions that modify the consequences of acute HIV infection.
Journal ArticleDOI

Enhancing SIV-specific immunity in vivo by PD-1 blockade

TL;DR: In this article, the authors investigated the safety and immune restoration potential of blockade of the co-inhibitory receptor programmed death 1 (PD-1) during chronic simian immunodeficiency virus (SIV) infection in macaques.
Journal ArticleDOI

B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

TL;DR: Neutrophils around the marginal zone (MZ) of the spleen, a B cell area specialized in T cell–independent immunoglobulin responses to circulating antigen, are identified, which indicates that neutrophils generate an innate layer of antimicrobial immunoglOBulin defense by interacting with MZ B cells.
Journal ArticleDOI

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

TL;DR: It is reported here that SIV-infected mangabeys maintain preserved T lymphocyte populations and regenerative capacity and manifest far lower levels of aberrant immune activation and apoptosis than are seen in pathogenic SIV and HIV infections.